The SLC35A1 gene helps move sialic acid, a sugar your cells attach to many proteins and fats, into the part of the cell where these molecules are finished. If this transport does not work well, cells may make poorly coated proteins, which can affect brain development, movement, blood cells, and immune function. Pathogenic variants in the SLC35A1 gene can cause a rare inherited condition in which children may have developmental delay, low muscle tone, seizures, or low platelet counts.
What is a gene?
A gene is a stretch of DNA with instructions that your cells use to make molecules or regulate processes in the body. Some genes hold the directions for making proteins, the parts of cells that do much of the work. Other genes mostly help control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To look into this topic more closely, you can find more in the LearnHub.
Overview
SLC35A1Gene function
What if the gene works
The SLC35A1 gene helps move sialic acid, a sugar molecule, into the Golgi, a cell packaging area, where cells add it to proteins and fats. This supports normal cell surface structure, cell signaling, and the stability of some blood and immune cells.
Risk
What if the gene does not work
Variants in the SLC35A1 gene can cause a rare condition with developmental delay, low muscle tone, and blood or immune problems. Effects can range from milder to more severe, influencing when symptoms appear and which features develop.
Treatment
What does that mean for your treatment
No SLC35A1-specific treatment or drug selection approach is currently established in clinical guidelines. Research is ongoing on ways to restore sialic acid handling, but this has not yet changed routine care.
Conditions associated with SLC35A1
Gene function
What if the gene works
Inside your cells, the SLC35A1 gene helps move a key sugar building block to the place where many proteins and fats are finished. This step is central to how cells add sialic acid, a finishing sugar, to their surface. When this process runs normally, cells can maintain a smooth outer coating used for everyday communication and stability.
The SLC35A1 gene makes a transporter that carries activated sialic acid into the Golgi, the cell’s packaging center. This supplies the material needed for the last sugar steps on many proteins and fats.
One of its main roles is to help cells place sialic acid onto proteins and fats before they move to the cell surface or are released. This gives many molecules their usual final sugar coating.
These surface sugars help cells recognize and interact with each other in an orderly way. They also support the normal charge, stability, and behavior of many cell surface and circulating molecules.
What is a variant?
A genetic variant is a minor alteration in a gene’s DNA sequence. These changes are common and help shape normal differences among people, such as appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC35A1 gene can lower or block the cell’s ability to move sialic acid into the Golgi, the cell compartment that adds final sugar caps to many proteins and fats. As a result, SLC35A1 gene variants may reduce transporter stability, send it to the wrong place in the cell, or weaken its transport activity, leading to incomplete sialylation. Milder variants often leave some transport working, while more disruptive variants can remove most activity and are linked to earlier and broader features of SLC35A1-CDG.
How variants are linked to conditions
Pathogenic variants in the SLC35A1 gene cause SLC35A1-CDG, a rare inherited condition also called a congenital disorder of glycosylation. Reported signs often include developmental delay, low muscle tone, seizures, growth problems, and low platelets. Because this is a monogenic condition, finding disease-causing variants in both copies of the gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC35A1, risk is mainly shaped by inheritance, especially whether a child receives altered copies of the gene from both parents. There is not broadly confirmed evidence that lifestyle or everyday environmental factors meaningfully change SLC35A1-related risk, so personal concerns are best discussed with a doctor or genetic counselor.
Inheritance of SLC35A1 variants
For families asking how SLC35A1 gene variants are inherited, the established pattern for SLC35A1-related disease is autosomal recessive. This means a child usually inherits one variant in the SLC35A1 gene from each parent, while parents who carry one variant are often unaffected themselves. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is a carrier, and a 25% chance of a child with no familial variant.
What does my SLC35A1 result mean for my family?
For families, a harmful SLC35A1 result usually means close relatives could also be carriers, even if they have no symptoms. Brothers and sisters may also be affected or be carriers, depending on the gene changes they inherited. Family planning questions can come up because two carrier parents can have more than one child with the condition.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SLC35A1 gene, doctors use SLC35A1 genetic testing on a blood sample or saliva sample. A lab reads the DNA sequence to check for variants and may also look for missing or extra pieces of the gene. Results can show whether a variant is present and whether it may explain a person’s condition.
When should I consider getting a genetic test?
Testing for changes in the SLC35A1 gene may be considered when a child has signs of a rare inherited condition, such as developmental delay, low muscle tone, seizures, or ongoing low platelet counts, especially if the cause is unclear. It can also be relevant if a close family member has a confirmed SLC35A1-related condition.
A genetic result is only one part of your health story
Genetic test results can be very informative, yet what they reveal varies with both the condition and the kind of variant found. Over time, how the body functions is shaped by many factors, including age, environment, lifestyle, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, it can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to the drug differently. These differences are common and are one reason medication response is not the same for everyone. In some cases, genetic results can help explain why a person seems more sensitive to a medicine or gets less benefit from it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the SLC35A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response in routine care. If you have concerns about side effects, a medicine is not working as expected, or you have general questions about treatment, it is best to discuss them with your doctor or pharmacist.